1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FRY CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA USP37 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ZNF517 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA CLEC11A CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ZNF395 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ADCY9 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA AIF1 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA HRH2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA FKBP2 CTRPv2 pan-cancer AAC -0.17 2e-06
Download CSV